Obstructive sleep apnoea solved

Translate an idea into an actual solution.

Obstructive Sleep Apnoea (OSA) is diagnosed when throat and tongue muscles relax abnormally strong and block the air flow during sleeping. This disturbance not only causes snoring but briefly wakes up the patient as a result of a short suffocation panic. OSA is the most common sleep disorder and it affects over 300,000 people in Belgium alone. Nyxoah’s therapy consists of a tiny neurostimulator implanted in the chin area. The system stimulates the tongue nerve. This keeps the upper airway open throughout the night, avoiding sleep apnoea.

Disruptive solution requires discrete and minimally invasive surgery

The system that the Belgo-Israeli start-up Nyxoah has developed is compact and requires a simple implantation, just under the chin of the patient. This implant directly stimulates the tongue muscles when needed. This keeps the upper airway open throughout the night. The implant itself is wirelessly powered by a small activation chip that the patient wears under the chin on a disposable patch while sleeping.

Charging during the day gives you a good sleep at night

Since most of the complexity lies in the activation chip, the implant is kept simple, giving it a long lifetime. While Nyxoah mastered the required technology, they needed a partner to help create a complete system that guarantees a user-friendly approach for patients, doctors, and surgeons.

Making it easy for all users

Our designers and engineers developed a new solution to charge the implant and wear the device during the night. As a side effect, our designs are patented and are now an important element of Nyxoah’s IP.